Radioimmunotherapy with Lu-177-DOTA-Rituximab. Final results of a phase I/II study in 31 patients with relapsing follicular, mantle cell and other indolent B-cell lymphomas
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2012）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要